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The prevalence of obesity in adults and children has increased globally at an alarming
rate. Mounting evidence from both epidemiological studies and animal models indicates
that adult obesity and associatedmetabolic disorders can be programmed by intrauterine
and early postnatal environment- a phenomenon known as “fetal programming of
adult disease.” Data from nutritional intervention studies in animals including maternal
under- and over-nutrition support the developmental origins of obesity and metabolic
syndrome. The hypothalamic neuronal circuits located in the arcuate nucleus controlling
appetite and energy expenditure are set early in life and are perturbed by maternal
nutritional insults. In this review, we focus on the effects of maternal nutrition in
programming permanent changes in these hypothalamic circuits, with experimental
evidence from animal models of maternal under- and over-nutrition. We discuss the
epigenetic modifications which regulate hypothalamic gene expression as potential
molecular mechanisms linking maternal diet during pregnancy to the offspring’s risk of
obesity at a later age. Understanding these mechanisms in key metabolic genes may
provide insights into the development of preventative intervention strategies.
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Introduction
The number of reported cases of obesity has risen dramatically in the developed world and is one
of the greatest public health challenges we face due to the projected burden on future health care
services. Current estimates suggest that more than a third of adults in the United States are obese
and according to the Department of Health in the UK, more than half of the adult population is
either overweight or obese (Department of Health, 2014). Obesity is also a risk factor for a number
of other associated metabolic disorders such as type 2 diabetes, cardiovascular disease, hyperten-
sion, stroke, and osteoarthritis (Abbasi et al., 2002; Steinberger et al., 2003; Qatanani and Lazar,
2007; Chiarelli and Marcovecchio, 2008). It is undoubtedly multifactorial, occurring as a result of
both complex genetic traits and environmental factors.
The gene-environment interaction represents a likely factor in the recent demographic shift
toward a more obese phenotype. This comes as growing evidence shows that fetal and early postna-
tal environments influence the risk of developing obesity. Epidemiological and animal studies show
that nutritional imbalances such as under- and over-nutrition during critical ontogenic periods
induce persistent physiological alterations. These changes are strongly associated with metabolic
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disorders such as obesity, type 2 diabetes, and cardiovascular
disease in adult offspring (Blackmore and Ozanne, 2013; Duque-
Guimaraes and Ozanne, 2013; Hanson and Gluckman, 2014).
Programming of metabolic disorders in humans by intrauter-
ine experiences was first explored by Barker et al. (1990). They
observed a strong association between low birth weight and the
risk of cardiovascular disease and type 2 diabetes in adulthood
(Barker et al., 1990, 1993; Hales et al., 1991). Other retrospective
analyses have also demonstrated that early life experiences can
increase the susceptibility of developing metabolic disorders in
adulthood (Ravelli et al., 1976, 1999). These observations led to
the fetal programming hypothesis also known as “Developmen-
tal origins of health and disease (DOHaD)” or “thrifty pheno-
type” hypothesis. This theory suggests that the fetus will adapt to
adverse changes in the intrauterine environment such as mater-
nal undernutrition. However, increased nutritional availability in
postnatal life can result in the development of metabolic syn-
drome (Hales and Barker, 2001). Emerging evidence confirms
that maternal overnutrition during pregnancy and increased
birth weight also increase the incidence of obesity in the off-
spring. Thus, the relationship between human birth weight and
the potential of developing adult obesity and other metabolic dis-
orders is a “U-shaped” curve with risk from bothmaternal under-
and over-nutrition (Curhan et al., 1996; Pettitt and Jovanovic,
2001; Ong, 2006).
Importantly, fetal programming by both maternal under-
and over-nutrition involves perturbations in the hypothalamic
appetite regulatory systems which are established during early
development (McMillen et al., 2005; Bouret, 2009; Stevens et al.,
2011; Ross and Desai, 2014). The hypothalamus controls food
intake and energy expenditure and is a prime target of develop-
mental programming bymaternal nutritional imbalance that pre-
disposes the offspring to permanent risks of metabolic disorders.
Epigenetic alterations of key metabolic genes in the hypothala-
mus are central in regulating this process. The purpose of this
review is to discuss evidence from recent studies supporting
hypothalamic programming of obesity and the role of epige-
netic gene regulation in mediating phenotypic alterations in the
offspring as a result of a maternal nutritional insult.
Hypothalamic Neuronal Circuits
Controlling Energy Balance
Energy balance is controlled centrally, predominantly by the
hypothalamus. The principal area containing these circuits is the
arcuate nucleus (ARC), but within the hypothalamus the par-
aventricular nucleus (PVN) and the dorsomedial hypothalamus
(DMH) also have a role in the regulation of energy balance. The
ARC is known as the “feeding” center of the brain. It is a region
close to the 3rd ventricle and the median eminence. This region
of the brain has a “leaky” blood brain barrier, which allows the
access of peripheral hormones to this part of the brain. The ARC
contains both anorexigenic and orexigenic neurons. Together,
the peptides released from these two sets of neurons counterbal-
ance each other to control food intake and energy expenditure
and ultimately have a major role in the control of body weight.
Anorexigenic ARC Neurons
The most studied anorexogenic neurons in the ARC are pro-
opiomelanocortin (POMC) neurons as they synthesize POMC as
well as cocaine and amphetamine regulated transcript peptides
(CART), both of which decrease food intake. They are almost
exclusively located in the ARC and project mainly to the PVN,
lateral hypothalamus (LH) and the brainstem areas, which are all
associated with control of energy balance (Figure 1).
POMC can be cleaved to numerous peptides includ-
ing adrenocorticotrophic hormone (ACTH), β-endorphin and
α-melanoctye stimulating hormone (α-MSH). The most widely
studied anorexigenic neuropeptide in the ARC is α-MSH, which
acts as an agonist at melanocortin 3 receptors (MC3R) and
melanocortin 4 receptors (MC4R) in the hypothalamus. These
receptors are highly expressed on second order neurons in the
PVN and their activation leads to a reduction in food intake
and an increase in energy utilization. Understanding the function
of POMC has been enhanced by the use of knock-out models.
The global POMC knock-out mouse has hyperphagia, leading
to excessive body weight gain (Coll et al., 2005). Additionally,
FIGURE 1 | Hypothalamic signaling controlling energy balance. POMC
and AgRP/NPY neurons project from the ARC to the PVN to control food
intake and energy balance. The signaling from these neurons can be
influenced by GCs, Leptin, and Insulin. ARC, arcuate nucleus; AgRP,
agouti-related peptide; GCs, glucocorticoids; GR, glucocorticoid receptor; IR,
insulin receptor; LepR, leptin receptor; MC4R, melanocortic 4 receptor;
α-MSH, α melanocyte stimulating hormone; NPY, neuropeptide Y; POMC,
pro-opiomelanocortin; PVN, paraventricular nucleus; Y1/Y5, Y1 and Y5
receptors; 3V, 3rd Ventricle.
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deletion of either the MC3R (Butler et al., 2001) or MC4R
(Huszar et al., 1997) also leads to an obese phenotype with
increased fat mass. Furthermore, genetic mutations in the POMC
gene have been shown to cause obesity in patients (Krude et al.,
1998; Challis et al., 2002; Farooqi et al., 2006; Creemers et al.,
2008). Therefore, POMC derived peptides clearly have roles in
reducing food intake to control body weight.
The other major anorexigenic neuropeptide in the ARC is
CART, however, it is less widely studied than POMC, due to a
lack of understanding of the receptors for this peptide (Lau and
Herzog, 2014). CART is released from the same ARC neurons
that release POMC and has a similar effect to reduce food intake
and increase energy expenditure. But in contrast to POMC,
CART is more widely expressed throughout the brain and the
peripheral tissues (Douglass et al., 1995; Couceyro et al., 1997;
Ekblad, 2006; Vrang, 2006; Kasacka et al., 2012). When CART
knock-out mice are fed a high caloric diet, they demonstrate the
expected increases in food intake and body weight (Asnicar et al.,
2001; Wierup et al., 2005; Moffett et al., 2006), giving an insight
into the role of CART in energy balance.
Orexigenic ARC Neurons
The orexigenic neurons in the ARC primarily release neu-
ropeptide Y (NPY), agouti-related peptide (AgRP), and γ-
aminobutyric acid (GABA) to increase food intake. Their cell
bodies are located in the ARC and the neurons project to other
hypothalamic regions including the PVN, DMH, perifornical
area (Karatsoreos et al., 2010), LH, and the medial preoptic area
(MPO) (Chronwall et al., 1985; Morris, 1989).
The role of these neurons in the control of food intake has
been highlighted in a recent study where each of the individ-
ual components were deleted, demonstrating that NPY, AgRP,
and GABA have a synergistic role in the control of food intake
(Krashes et al., 2013). However, ablation of the whole orexigenic
ARC neuron postnatally leads to starvation of the animal (Gropp
et al., 2005; Luquet et al., 2005), indicating the essential role of
these neurons in regulating appetite.
AgRP is an antagonist at the MC4R, blocking the effects of
α-MSH in the energy regulating pathway and thereby increasing
food intake. Interestingly, deletion of AgRP from the neuron can
result in an unchanged (Corander et al., 2011) or a very mild phe-
notype, which is only seen in older mice (Wortley et al., 2005).
These mice have a decrease in body weight from 6 months of
age, associated with an increase in energy expenditure. Although,
knocking out the peptide has such a small effect, administra-
tion of AgRP by intracerebroventricular (icv) injection increases
food intake, which is sustained for up to a week (Rossi et al.,
1998; Hagan et al., 2000). More recently, using genetic manipula-
tion it was noted that AgRP has a role in prolonged, rather than
short-term feeding (Krashes et al., 2013).
NPY binds to Y1 and Y5 receptors in the hypothalamus to
exert its effects on food intake and energy balance (Morton
and Schwartz, 2001). Its role in these processes has been clearly
demonstrated in a well-designed study, where an icv injec-
tion of NPY induced feeding in rodents and which was main-
tained for a number of hours (Clark et al., 1984). Furthermore,
repeated injections of NPY over several days resulted in increased
food intake, body weight and adiposity (Stanley et al., 1986).
Conversely, injecting an antisense oligonucleotide or antiserum
to NPY decreased food intake and body weight gain in rats
(Shibasaki et al., 1993; Hulsey et al., 1995). Curiously, global
knock-out of NPY results in normal body weight and food intake
as well as a normal response to a 48 h fast (Erickson et al., 1996).
This must be a consequence of other pathways compensating in
the absence of NPY.
As well as the two neuropeptides, the neurotransmitter GABA
is also released from orexigenic ARC neurons. From studies
using designer receptors exclusively activated by designer drug
(DREADD) technology, it appears that GABA has a similar role
to NPY, such that it can influence the initial phase of feeding and
can act as a substitute for NPY (Krashes et al., 2013). Together,
the three factors released from orexigenic ARC neurons promote
an increase in food intake.
Glucocorticoids and the Regulation of Food
Intake
Glucocorticoids (GCs) are steroid hormones secreted by the
adrenal gland under the control of hypothalamic-pituitary-
adrenal (HPA) axis and are known to have a role in the reg-
ulation of food intake as well as energy balance. They exert
their effects by binding and activating the glucocorticoid recep-
tor (GR). This triggers a cascade of events resulting in GR
acting as a transcription factor and binding to glucocorticoid
response elements (GREs) such as those present in the pro-
moter regions of AgRP (Lee et al., 2013) and NPY (Misaki et al.,
1992).
Models of GC excess in mice have highlighted their ability
to increase food intake and body weight. Both active cor-
ticosterone (equivalent to cortisol in humans) and inactive
11-dehydrocorticosterone (cortisone in humans) can mediate
these effects (Karatsoreos et al., 2010; Harno et al., 2013; Mor-
gan et al., 2014). Furthermore, these models mimicked metabolic
syndrome and Cushing’s syndrome, both of which are associ-
ated with glucocorticoid excess and are characterized by hyper-
phagia. Similar clinical symptoms can be seen as a result of
the adverse effects seen with administration of chronic synthetic
“steroid” (glucocorticoid) treatment. In addition, adrenalectomy
and removal of endogenous GCs leads to a reduction in body
weight and food intake in genetically obese rodents (Marchington
et al., 1983; Makimura et al., 2000).
GCs also have a role in altering the expression of both
ARC orexigenic and anorexigenic neuropeptides. This has been
explored by either depleting the levels of GCs or significantly
increasing the amounts of GC exposure. AgRP is positively reg-
ulated by GCs in multiple studies (Savontaus et al., 2002; Coll
et al., 2005; Kim et al., 2013; Lee et al., 2013). The results are less
clear cut for NPY with studies demonstrating that dexametha-
sone, a synthetic GC, increases NPY expression (Goto et al., 2006;
Yi et al., 2012), but corticosterone, the endogenous GC in rodents,
has no effect (Coll et al., 2005). The control of POMC by GCs
is also controversial with studies showing both positive (Savon-
taus et al., 2002; Uchoa et al., 2012) and negative (Beaulieu et al.,
1988; Makimura et al., 2000; Gyengesi et al., 2010) regulation
by GCs.
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Other Peripheral Hormones Acting on Neural
Networks
Other peripheral hormones, principally leptin and insulin, can
cross the blood brain barrier to act in the hypothalamus on ARC
orexigenic and anorexigenic neurons. Both of these peripheral
hormones have receptors on both classes of neurons, allowing
these factors to affect firing and signaling of the neuron and in
turn have an effect on food intake and energy balance.
Leptin, released by adipocytes, circulates in direct proportion
to the amount of adipose tissue (Considine et al., 1996). It is
anorexigenic and some of its effects are mediated by POMC neu-
rons as a result of increasing α-MSH secretion (Cowley et al.,
2001; Munzberg et al., 2003; Guo et al., 2004). In addition, orexi-
genic AgRP/NPY neurons also express leptin receptors (Elmquist
et al., 1998) and leptin reduces the expression of both AgRP and
NPY neuropeptides (Stephens et al., 1995; Mizuno and Mobbs,
1999). Evidence for the functional role of leptin has come from
studies where leptin has been administered centrally in rodents
and decreases food intake and body weight (Campfield et al.,
1995; Weigle et al., 1995). There are also studies in obese chil-
dren with congenital leptin deficiency, where leptin replacement
has been able to reduce body weight and hyperphagia (Farooqi
et al., 1999). However, leptin is not a suitable treatment for most
patients with obesity as they already have high circulating levels
of leptin because they have developed leptin resistance, a con-
dition where leptin is unable to induce its effect of lowering
of food intake and therefore body weight (Schneeberger et al.,
2014).
Insulin can act in the ARC to produce an anorexigenic effect,
reducing food intake and body weight (Woods et al., 1979).
Insulin receptors are widely expressed in the brain and co-
localize with both POMC and AgRP neurons (Marks et al.,
1990; Benoit et al., 2002). Activation of the insulin signaling
pathway in the ARC decreases NPY and AgRP expression as
well as increasing the expression of POMC to give the anorex-
igenic effect (Schwartz et al., 1992; Sipols et al., 1995; Benoit
et al., 2002; Plum et al., 2006). As with leptin, there is evi-
dence for central insulin resistance, decreasing the ability of
insulin to reduce food intake in obese patients (Hallschmid et al.,
2008).
Another peripheral hormone that plays an important role in
the regulation of energy balance is the gut-derived orexigenic
peptide hormone, ghrelin. It acts via the growth hormone
secretagogue receptor (GHS-R) which is present at a high
density in the hypothalamus, specifically in the nuclei involved
in body weight and food intake regulation such as the ARC,
ventromedial hypothalamus, DMH, and PVN (Mitchell et al.,
2001; Zigman et al., 2006). The ghrelin-induced increase in food
intake is mediated by the NPY/AgRP pathway as genetic ablation
or pharmacological inactivation of AgRP and NPY blocks the
orexigenic effects of ghrelin (Nakazato et al., 2001; Shintani et al.,
2001; Chen et al., 2004). Moreover, central administration of
ghrelin to rats leads to an increase in the mRNA expression of
both NPY and AgRP (Kamegai et al., 2001; Nakazato et al., 2001;
Shintani et al., 2001).
Experimental Evidence for the
Programming of Appetite and Obesity
There are many examples within the literature demonstrating a
link between maternal nutritional insults and detrimental effects
on the fetus. Both maternal under- and over-nutrition have been
extensively described with additional factors such as the tim-
ing of the insult, the gender of the offspring and importantly,
the severity of the nutritional change leading to complex out-
comes. As a result, deciphering the pathways and the key genes
affected is challenging. The hypothalamic appetite signaling path-
way is imperative in these processes and is altered following per-
turbations in the maternal nutritional environment in fetal and
postnatal offspring.
Maternal Undernutrition and its Effects on the
Offspring
Maternal undernutrition is recognized as being a cause of
fetal programming leading to the offspring having an increased
propensity to develop hypertension, type 2 diabetes and cardio-
vascular disease (Barker, 2005). The Dutch famine (1944–1945)
has been the basis for initial pioneering epidemiological studies
demonstrating the negative associations between maternal envi-
ronment and disease outcomes in the offspring (Ravelli et al.,
1976). One of themain characteristics of maternally programmed
offspring is altered birth weight, which was a marker that these
studies initially utilized to identify programmed offspring. It was
found that mothers exposed to famine during early gestation had
offspring with normal birth weight but with an increased pos-
sibility of becoming obese, whereas mothers exposed to famine
later in pregnancy had offspring with lower birth weights (Ravelli
et al., 1976; Sharkey et al., 2009). These findings clearly show that
exposing the fetus to maternal undernutrition during different
times of fetal development can induce differential outcomes. Lon-
gitudinal analysis of this cohort revealed that at approximately
50 years of age the maternally-programmed offspring had com-
promised glucose tolerance and higher insulin concentrations
(Ravelli et al., 1999; Mostyn and Symonds, 2009). Extensive anal-
ysis of these individuals has led to the understanding that these
changes may be a consequence of impaired insulin secretion (de
Rooij et al., 2006). However, the precise mechanisms governing
these changes are difficult to elucidate due to the restrictions of
using the human model. This is particularly true when trying to
assess the hypothalamic regulation of energy balance. As a result,
several animal models have been established to characterize the
potential pathways involved.
Caloric Restriction, Intrauterine Artery Ligation, and
Twinning as Models of Adverse Events in Pregnancy
A range of programming models have been developed to mimic
the human maternal undernutrition paradigm. These animal
models are critical in defining the systems and underlying mech-
anisms that may be involved in the increased susceptibility of
the children to develop disease in adulthood, following expo-
sure to maternal nutritional programming. These models have
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included caloric restriction, intrauterine artery ligation, and twin-
ning. Caloric restriction has been one of the most common
paradigms, with studies reducing the calorie intake by 50–70%
in the earlier studies (Delahaye et al., 2008; Breton et al., 2009)
and then to more moderate levels in more recent studies (Stevens
et al., 2010). Initially the high levels of caloric restriction were
essential in defining changes that may be occurring in mothers
exposed to famine. However, using moderate restriction could be
more applicable to mimicking the effects of women dieting dur-
ing the initial periods of conception to increase their chances of
conceiving or because of social pressures to be thin. These studies
have been vital in highlighting the effects of maternal undernutri-
tion on hypothalamic mechanisms in the fetus. Nevertheless, the
inconsistencies between the investigations about the severity and
timing of the insult should be addressed.
One of the proposed mechanisms for maternal programming
of the fetus is altered placental blood flow leading to the birth
of small for gestational age babies (Sanders et al., 2004). Bilat-
eral uterine ligation techniques have been developed as a tool
for investigating the effects of placental insufficiency (Gagnon,
2003). Glucose is a necessary component of the maternal and
fetal system, which the fetus will utilize to aid many developmen-
tal processes. Accordingly, any induced or natural decreases in
blood flow can dramatically reduce the levels of glucose that the
fetus is exposed to, leading to hypoglycaemia. This in turn can
impact on insulin levels and pancreatic β-cell function. Conse-
quently, the fetus must adapt to this situation by altering other
metabolic parameters with expected adverse outcomes such as
impaired glucose tolerance. However, there is evidence to sug-
gest that this model of maternal programming and its outputs
are difficult to reproduce (Neitzke et al., 2008). Therefore, mod-
els of bilateral uterine artery ligation require further development
before significant conclusions can be made about any changes
that are observed.
Over the years the number ofmothers giving birth to twins has
risen due to artificial reproductive technology and multiple ovu-
lations, because mothers are having children later in life (Blon-
del et al., 2002; Ombelet et al., 2006; Muhlhausler et al., 2011).
More recently, twins have been found to have some similarities
with programmed offspring, having reduced birth weight, poten-
tially due to the twins being exposed to a maternal environment
where the fetuses must compete with each other for nutrition
(Rumball et al., 2008). Additionally, twins have a reduced pla-
centa size, as well as being in a restricted space. This may alter
their developmental trajectory to provide compensatory mecha-
nisms to ensure their survival. Studies have already found that
these possible compensatory mechanisms can lead to altered
glucose regulation and higher fat mass in adulthood (Poulsen
et al., 1997; Ribel-Madsen et al., 2012). Despite these findings
there are inconsistencies in the development of diseases in adult
twins (Phillips et al., 2001; Muhlhausler et al., 2011). This may
be because these investigations have omitted to use singletons
as their control and therefore, it is difficult to ascertain if any
changes are because of the inherited genotype of the animal or if
they are caused by the maternal environment (Muhlhausler et al.,
2011). Nevertheless, some studies have compared their data to
effects seen in singletons. They have found changes similar to
maternally undernourished animals with impaired glucose and
insulin signaling and altered hypothalamic pathways (Rumball
et al., 2008; Begum et al., 2012) indicating that these mechanisms
are important in programming.
The Effects of Maternal Undernutrition on the
Hypothalamic Appetite Signaling Pathway
The development of a functional hypothalamus occurs in two
phases, which involves neurogenesis and the formation of func-
tional circuits (axon growth and synaptogenesis). In precocial
species such as humans, sheep and non-human primates, the
development of hypothalamic neural projections occurs at the
fetal stage. However, in altricial rodents the hypothalamus is
immature at birth and development continues during the first
2 weeks of postnatal life when neurons send axonal projections
to their target sites and functional synapses are formed (Bouret,
2010). As a result the rodent hypothalamus is not fully formed
until after weaning. Thus, any changes in thematernal nutritional
environment during these critical periods will severely impact
on this system potentially altering the offspring’s developmen-
tal trajectory. Several studies on maternal perinatal undernutri-
tion in rodent models have produced key evidence that these
programmed offspring have low birth weight, exhibited hyper-
phagia in postnatal life and develop obesity, insulin resistance in
adulthood (Vickers et al., 2000; Yura et al., 2005). This hyper-
phagia is exacerbated when the offsprings are fed high caloric
diet in the post-weaning period (Vickers et al., 2000; Yura et al.,
2005). Moreover, alterations in hypothalamic cell proliferation
and impaired axonal elongation have been observed in the peri-
natally undernourished offspring (Delahaye et al., 2008; Breton
et al., 2009; Garcia et al., 2010). These changes modify the density
of the NPY and POMC neurons. This could have direct con-
sequences on the animal’s food intake and energy expenditure
and depending on which neurons are affected it could increase
food consumption and body weight. Supporting evidence for this
was provided by a study which showed a greater level of food
intake as a direct result of the maternal insult (Garcia et al.,
2010).
In addition to structural variations in the hypothalamus, these
models have also presented modifications in the expression of
ARC neuropeptides that have a central role in the energy regu-
lating pathway. This includes the anorexigenic POMC, and the
orexigenic neuropeptides, AgRP and NPY. Despite clear dif-
ferences in the severity and timing of the nutritional insult,
the outcome of maternal undernourishment is consistent, with
increased hypothalamic NPY and AgRP and decreased POMC
gene expression in postnatal rodent offspring (Lopez et al., 2005;
Delahaye et al., 2008; Breton et al., 2009; Cripps et al., 2009; Shin
et al., 2012).
As the hypothalamus develops postnatally in rodents, animal
models that specifically target the postnatal period have been
developed. This has been done by adjusting the litter size in
rats and mice. It has been found that pups raised in large lit-
ters (therefore less maternal milk) have attenuated pre-weaning
growth. This was associated with an increased number of NPY
neurons and higher NPY concentrations in the ARC (Plagemann
et al., 1999c). These results show that postnatal undernutrition in
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rats leads to alterations in hypothalamic neural circuits regulating
food intake and body weight.
Whilst the rodent model has been extremely useful for char-
acterizing maternal programming paradigms, the length of ges-
tation and the level of hypothalamic development during this
time is not comparable to humans (Symonds and Budge, 2009;
Bouret, 2010). As a result findings from species that are more
developmentally similar to humans, such as sheep, are vital in
enhancing our further understanding. These studies have shown
that moderate levels of maternal undernutrition during early ges-
tation led to increases in GR expression levels but no changes in
POMC or NPYmRNA expression at the fetal stage (Stevens et al.,
2010; Begum et al., 2013). However, evidence from higher mam-
mals such as baboons have shown a decrease in POMC expres-
sion and increased NPY expression in the baboon fetus (Li et al.,
2013). Therefore, changes may become apparent depending on
the insult and the species investigated.
There is a general lack of studies analyzing adult offspring.
This is problematic because the impact of programming on the
susceptibility of the adult offspring to develop diseases is the key
issue. A few longitudinal studies have been reported (Stevens
et al., 2010; Begum et al., 2013). In these, it has been shown that
maternal undernutrition leads to increases in GR expression lev-
els which are sustained from fetal to adult life. There were also
associated decreases in POMC expression in adulthood which
may be a consequence of the change in GR (Stevens et al., 2010;
Begum et al., 2013).
The Effects of Maternal Overnutrition on the
Hypothalamic Energy Regulating Pathway
Over recent years the focus of research in the programming field
has moved from studying the effects of maternal undernutri-
tion to maternal overnutrition. Investigating this programming
paradigm has become increasingly vital due to the rise in the lev-
els of obesity within developed countries such as the USA and
UK. Partly to blame for this surge in obesity is the increased
consumption of high caloric foods by the mothers, combined
with reduced levels of exercise. The number of epidemiological
studies establishing a clear link between increased maternal body
mass index and the offsprings’ susceptibility to disease in adult-
hood are extensive (Oken et al., 2008; Drake and Reynolds, 2010;
Reynolds et al., 2010). An interesting study by Patti (2013), found
that mothers who underwent bariatric surgery had children with
a decreased propensity to develop obesity compared to offspring
born before the mother was subject to surgery. This further high-
lights the negative implications of maternal overnutrition for the
offspring (Patti, 2013).
Once again rodent models have been essential in detailing the
effects of maternal high fat diet on the offspring. These stud-
ies have not only described changes that occur during preg-
nancy, but also those that may take place during lactation (Guo
and Jen, 1995; Samuelsson et al., 2008; Tamashiro et al., 2009).
As expected, the outcome of these studies has been the devel-
opment of obesity in the offspring accompanied by impaired
insulin and glucose homeostasis, as well as many other outcomes
such as cardiovascular diseases (Williams et al., 2014). However,
unlike maternal undernutrition, the findings from the maternal
overnutrition studies have been conflicting and therefore, more
difficult to interpret. Whilst some studies are in agreement that
there are impaired anorexigenic and orexigenic nerve fiber pro-
jections from the ARC to the PVN (Bouret et al., 2008; Chen
et al., 2008; Kirk et al., 2009), the levels of neuropeptide expres-
sion are extremely diverse. For example, when the mothers were
fed a high fat diet throughout gestation and lactation there was
increased POMC mRNA and lower amounts of NPY expres-
sion in the programmed offspring (Chen et al., 2008). The rise
in POMC may have occurred to provide some form of com-
pensatory mechanism within these animals. In contrast, some
studies have shown decreases in POMC and NPY (Morris and
Chen, 2009), whilst another found increases in CART, NPY, and
AgRP (Lopez et al., 2005). Although the standard animal model
of maternal overnutrition during gestation and lactation, gives
rise to adverse effects in the offspring, it does not explain which
effects are caused by gestational and which by lactational expo-
sure to maternal high fat feeding. Indeed, Vogt et al. (2014), have
demonstrated the importance in the timing of the maternal insult
and the effects that this can have on fetal outcome. In this study
it was found that giving mothers a high fat diet during lactation
induced changes in the POMC and AgRP nerve fiber projections
in the hypothalamus (Vogt et al., 2014).
In the aforementioned study, one possible underlying mecha-
nism suggested to induce modified fiber projections was altered
insulin signaling (Vogt et al., 2014). Indeed, when the insulin
receptor on POMC neurons was ablated in offspring from moth-
ers fed a high fat diet, this led to a rescue in the previously
distorted nerve projections. As a result, this study is the first to
demonstrate a clear link between altered insulin signaling in the
hypothalamus and perturbations in the hypothalamic energy reg-
ulating pathways in a maternally programmed paradigm. Since
in humans, ARC neuronal projections arise during the third
trimester, these results indicate that changes in maternal glu-
cose metabolism during this critical window may have metabolic
effects on the offspring throughout life. This investigation did
not rule out the possibility of other mechanisms affecting the
structure of the hypothalamus and other studies have suggested
that changes in hypothalamic connections may also be asso-
ciated with altered leptin resistance (Kirk et al., 2009). These
findings have been essential in determining potential underly-
ing reasons for the changes that are being observed in mater-
nal programming paradigms. Nevertheless, there are still large
gaps in our knowledge of how nutritional insults impact on
the maternal and fetal interface such that they are affecting
peripheral regulators to modify central pathways in a negative
manner.
Another approach to studying postnatal overfeeding is by
reducing the litter size. Raising pups in small litters post birth
can potentially decrease competition for the mother’s milk and
therefore increase nutritional availability. As a result, there is a
greater chance of the pups developing obesity, hyperphagia, and
impaired glucose tolerance. Indeed, one study found that this
led to increased numbers of neurons producing the orexigenic
neuropeptide galanin in pups from reduced litters (Plagemann
et al., 1999b). Taken together, these results demonstrate that
exposure to prenatal or postnatal overnutrition in rodents results
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in substantial changes in the development of the hypothalamic
architecture.
Maternal Gestational Diabetes Programs the
Hypothalamic Neural Network Controlling
Appetite in Offspring
Gestational diabetes is a common complication predisposing off-
spring to obesity and diabetes. The effect of maternal insulin defi-
ciency on the offspring’s hypothalamic appetite regulating system
has been studied using rodents injected with the pancreatic islet
toxin streptozotocin (STZ) during early pregnancy to develop a
model of diabetes. The pups of diabetic mothers presented with
impaired metabolic regulation including increased glucose and
insulin levels, hyperphagia and increased body weight. In addi-
tion, they exhibited structural alterations affecting the density of
AgRP and anorexigenic αMSH containing fibers in the PVNwith
altered leptin sensitivity (Steculorum and Bouret, 2011b). In a
similar animal model, Plagemann et al. (1999a) has shown that
offspring of diabetic dams have an increased number of galanin
and NPY containing neurons (Plagemann et al., 1999a). Taken
together, these results highlight that maternal gestational dia-
betes leads to malprogramming of hypothalamic orexigenic and
anorexigenic systems in the offspring, contributing to metabolic
disorders later in life. Perhaps more importantly, these acquired
alterations in hypothalamic appetite related circuits can be pre-
vented by normalizing gestational hyperglycaemia (Franke et al.,
2005).
Programming Affecting Leptin, Insulin, Ghrelin
and Glucocorticoids, and the Impact on their
Role in the Hypothalamus
As mentioned above, leptin can bind to ARC anorexigenic and
orexigenic neurons influencing transcriptional activity. Increases
in leptin levels are critical for the developing brain in assist-
ing with increased fiber density and ensuring correct axonal
projections from the ARC to other areas of the hypothalamus.
Additionally, leptin is crucial for neuronal differentiation and
migration (Bouret et al., 2004; Udagawa et al., 2007). As a result, it
is clearly evident that this hypothalamic energy regulating path-
way is susceptible to changes in leptin levels which could be
impaired in offspring of programmed mothers. Indeed, stud-
ies outlined above found altered leptin levels contributing to
increased food intake in the offspring (Delahaye et al., 2008; Gar-
cia et al., 2010). However, the exact mechanisms leading to these
changes are yet to be elucidated.
Many studies have shown impaired insulin regulation in
fetuses from nutritionally programmed mothers (Snoeck et al.,
1990; Chamson-Reig et al., 2006; Theys et al., 2009; Todd et al.,
2009). It is understood that these changes are occurring because
of modifications in the pancreas, such that there is deficient
insulin production and secretion. Further evidence suggests that
a maternal low protein diet can lead to pancreatic islets with defi-
cient responses to glucose stimulation (Theys et al., 2009). There
is also significantly reduced β-cell proliferation found in postna-
tal offspring (Chamson-Reig et al., 2006). In part these changes in
the pancreas could be a compensatory mechanism developed by
the fetus in response to hypoglycaemia experienced as a conse-
quence of insufficient blood flow across the placenta. It is impor-
tant to note that only one investigation has clearly described a
direct link between peripheral insulin exerting its action on the
insulin receptor in the hypothalamus and impaired POMC nerve
fiber projections in the hypothalamus (Vogt et al., 2014).
Recently, ghrelin has been shown to play an important role
in the normal development of ARC neural projections in neona-
tal mice and perturbations in its action during early life can
affect leptin sensitivity and cause lifelong metabolic disturbances
(Steculorum et al., 2015). Furthermore, acute ghrelin injection to
mouse pups during second week of postnatal life lead to altered
levels POMC and NPY mRNA (Steculorum and Bouret, 2011a).
These results highlight the importance of the effect of ghrelin in
influencing normal hypothalamic development. Moreover, ghre-
lin levels are altered by early life nutrition decreasing its ability to
activate ARC neurons (Collden et al., 2015).
Additionally, although key regulators of the hypothalamic
pathway such as leptin have been investigated in relation to
maternal programming paradigms, very few studies have exam-
ined GCs. In particular, changes in the GR have been shown
to influence the expression of neuropeptides and therefore, GR
presents itself as an ideal candidate for further study. Indeed
Li et al. (2013) and Begum et al. (2013) have demonstrated
clear increases in hypothalamic GR expression associated with
adverse outcomes within the offspring of maternally undernour-
ished baboons and sheep, respectively. These studies highlight
the need for more research to be carried out on the role of
GR and other hypothalamic regulators, which the field currently
lacks.
Gender Specific Effects of Maternal
Programming within the Offspring
Whilst there has been much work carried out to determine the
effects of maternal programming, some investigations have failed
to take into account the possibility of gender specific differences
in the offspring. The possibility of sexually dimorphic outcomes
has been clearly highlighted in several recent studies (Todd et al.,
2009; Matthews and Phillips, 2012; Begum et al., 2013). For
example, in maternally undernourished offspring it was found
that males had an increased propensity to reduced insulin lev-
els and were more sensitive to changes in insulin (Todd et al.,
2009). Evidence from the literature suggests that this may be
caused by the male brain being more sensitive to the nutritional
alterations that are associated with leptin and insulin resistance
(Clegg et al., 2003). Furthermore, it was found that male off-
spring from undernourished ewes developed an increase in fat
mass which was not observed in the females (Begum et al., 2013).
It could be hypothesized that these changes may have occurred
as a consequence of decreased central actions of insulin, leading
to lower levels of POMC expression and reduced inhibition of
food intake. Investigations detailing the effects of maternal pro-
gramming on the hypothalamic energy regulating pathway have
found associated changes in leptin and insulin levels (Delahaye
et al., 2008; Vogt et al., 2014). These peptides can be regulated
by the levels of estrogen, which could provide a compensatory
mechanism in females to circumvent the effects of under- or
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over- nourishment. However, more work needs to be carried out
in order to fully understand sexually dimorphic changes as a
consequence of maternal programming.
Molecular Mechanisms Underlying
Developmental Programming of Obesity
The literature clearly demonstrates that environmental insults
during critical periods of fetal development and early postnatal
life can influence energy expenditure pathways, with permanent
consequences for obesity risk. One plausible explanation is
that nutritional insults during early life may interfere with
organogenesis and thus altering organ structure and func-
tion (Langley-Evans, 2009). Another mechanism to explain
developmental programming is epigenetic modifications, which
regulate gene expression patterns in a spatial and temporal man-
ner. Epigenetic marks are established during fetal development
and early postnatal life (Jaenisch and Bird, 2003). These marks
exhibit developmental plasticity in response to the environment
and are maintained throughout life. Therefore, perturbations to
such processes represent a principal candidate mechanism by
which early life nutritional insults can induce persistent phe-
notypic alterations in adulthood. Accordingly, there has been
recent growing interest in the role of epigenetic dysregulation of
appetite regulatory genes in metabolic disorders such as obesity
(Gluckman et al., 2009; Stevens et al., 2011; Waterland, 2014).
Epigenetic Mechanisms
Epigenetics is the study of stable alterations in gene activity that
occur without changes in the underlying DNA sequence. Epige-
netic modifications play a significant role in regulating chromatin
assembly, DNA replication and repair as well as gene expres-
sion during cell differentiation and development (Delage and
Dashwood, 2008). The candidate epigenetic mechanisms include
methylation of cytosines in CpG dinucleotides, posttranslational
modifications of histone proteins and micro-RNAmediated gene
regulation. Most importantly, these epigenetic modifications
function synergistically to maintain chromatin conformations in
a cell type specific manner to influence transcriptional activity.
Up to now, most of the studies of early life influences on epige-
netic regulation of genes have focused on DNA methylation and
a few on histone modifications. Therefore, the following section
will focus on describing these two mechanisms and the potential
influence they may have on central genes in the metabolic path-
ways of the fetus that may be altered as a consequence of maternal
programming.
Influence of DNA Methylation
DNA methylation is the most prominent, well-understood, and
highly stable epigenetic modification. It is involved in controlling
gene transcription, parental imprinting, X-chromosome inac-
tivation, and also in preventing retrotransposon activity and
genomic instability (Jones, 2012). The majority of DNA methy-
lation occurs at the C5 position of cytosine residues that are
adjacent to a guanine residue, known as a CpG dinucleotide.
DNA methylation is a covalent modification characterized by
the addition of a methyl group to the cytosine residue of DNA.
This is catalyzed by DNAmethyltransferases (DNMTs) which use
S-adenosylmethionine (SAM) as a cofactor and methyl donor.
DNMT3a and DNMT3b are de novo methyltransferases which
methylate cytosine residues at the previously unmethylated CpG
sites during germ cell development and embryogenesis. DNMT1
is a maintenance methyltransferase which predominantly methy-
lates hemimethylated CpG dinucleotides and copies the methy-
lation pattern in the newly synthesized DNA during replication
(Hermann et al., 2004).
DNA methylation can affect gene expression by two mech-
anisms: (1) by directly preventing the binding of transcrip-
tion factors to their recognition sites on the DNA (Watt and
Molloy, 1988), and (2) it can silence gene expression by pro-
moting the binding of methyl-CpG-binding proteins (MBPs)
which directly recognize methylated DNA and recruit transcrip-
tional co-repressor complexes containing histone deacetylases
(HDACs) and histone methyltransferases (Boyes and Bird, 1991;
Jones et al., 1998; Nan et al., 1998). As a result, DNA methy-
lation can effectively carry out its regulation of transcriptional
activity. In mammals, 70–80% of CpG dinucleotides are methy-
lated and the remaining unmethylated regions of the genome that
have higher levels of guanine and cytosine content, are clustered
together in CpG islands (Illingworth and Bird, 2009). There are
CpG islands in promoter regions of 70% of mammalian genes
and promoter CpG methylation is generally associated with gene
silencing (Bird, 2002).
Transcriptional Regulation by Histone Modifications
Histones are targets for epigenetic modifications which have pro-
found effects on transcriptional activity, because of their role in
packaging DNA into nuclear chromatin. The N-terminal region
of core histones designated as H2A, H2B, H3, and H4 are sub-
jected to numerous covalent modifications which influence both
chromatin organization and gene expression. The posttransla-
tional modifications of histones include acetylation, methylation,
phosphorylation, ubiquitination, and sumoylation (Kouzarides,
2007). Acetylation of histones at specific lysine residues is a
highly dynamic process regulated by two families of enzymes
with opposing actions, histone acetyltransferases (HATs) and
HDACs. HATs catalyze the transfer of acetyl groups to the lysine
residues utilizing acetyl-CoA as cofactor whereas HDACs func-
tion to reverse acetylation (Sterner and Berger, 2000). Histone
acetylation induces open chromatin conformation and corre-
lates with transcriptional competence. Specifically, acetylation at
histone 3 lysine 9 and 14 (H3K9/14ac) is associated with tran-
scriptional initiation and H3K36ac is associated with transcrip-
tional elongation. Histone methylation can be targeted at either
lysine or arginine residues by lysine (HKMT) or arginine (PRMT)
methyltransferases respectively. Histone arginine methylation is
involved in transcriptional activity whereas lysine methylation
has been associated with either activation or repression depend-
ing on the residuemodified. For example, methylation of H3K4 is
associated with transcriptional activation whereas methylation of
H3K9 and K27 correlates with gene silencing (Kouzarides, 2007).
Thus, combinations of different histone modifications can influ-
ence the regulation of the opening and closing of the chromatin
resulting in activation or repression of a given gene. Many studies
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have used these patterns of histone modifications, termed the
“histone code,” as a marker for epigenetic analysis within their
models.
Epigenetic Programming of Obesity: Candidate
Gene Studies Vs. Genome Wide Association
Studies
Given that epigenetic modifications are influenced by environ-
mental perturbations, several groups have investigated the effect
of maternal nutrition on the epigenetic changes of key hypotha-
lamic genes regulating energy balance and thereby impacting
on obesity in the offspring. These are discussed in the fol-
lowing sections of the review. A candidate gene approach has
several strengths, narrowing the focus on the role of specific
genes enabling direct phenotypic correlations to be made with
increased statistical power. However, this approach does not
further the understanding of the role of possible alterations
in novel genes or pathways in the offspring, which ultimately
shape developmental trajectories. This highlights the need for
the genome-wide association study (GWAS) to unravel novel
pathways involved in fetal programming of obesity. Accordingly,
a few studies have focused on the impact of in utero environ-
mental insults on the offspring’s genome-wide epigenetic alter-
ations (Altobelli et al., 2013; Crudo et al., 2013; Suter et al.,
2014). Although these studies are instrumental in identifying
novel genes and pathways associated with fetal programming,
they have limitations such as low statistical power with multiple
testing problems (Amos et al., 2011). Thus, future studies should
combine genome-wide analysis with candidate-gene approaches,
which are key to identifying the mechanisms involved in the
increased risk of metabolic disorders in the offspring.
Epigenetic Effects on Hypothalamic POMC as a
Consequence of Maternal Programming
In addition to genetic polymorphisms in POMC (Krude et al.,
1998; Challis et al., 2002; Farooqi et al., 2006; Creemers et al.,
2008), epigenetic variations could contribute to an individual’s
risk of obesity (Kuehnen et al., 2012). The anorexigenic POMC
is a likely target for epigenetic modifications by programming
because there is good evidence for its regulation by promoter
methylation (Newell-Price et al., 2001). The POMC gene has two
CpG islands, one identified at the 5′-promoter region and one
downstream around the intron 2 and exon 3 boundary (Newell-
Price, 2003; Kuehnen et al., 2012). However, the POMCpromoter
regions necessary for the regulation of the POMC gene in the
pituitary, and the hypothalamus, are different. In the hypotha-
lamus its expression is regulated by two highly conserved distal
neuronal enhancers, nPE1 and nPE2 located 10–12 kb upstream
of the transcriptional start site (de Souza et al., 2005). Sev-
eral studies have illustrated that an altered nutritional milieu
perinatally can program epigenetic changes in the key regu-
lator elements of the POMC promoter thereby affecting the
appetite signaling pathway and inducing an obese phenotype
in the offspring. For instance, maternal undernourishment dur-
ing the periconception period in sheep leads to fetal hypothala-
mic POMC hypomethylation in a region that is closely related
to the nPE1 and nPE2 POMC enhancer regions (Stevens et al.,
2010, 2011). Another investigation by Plagemann et al. (2009)
demonstrated that neonatal overnutrition in rats was associated
with hypermethylation of CpG sites within the Sp1 binding site,
which is required for the leptin and insulin mediated expres-
sion of POMC in the hypothalamus. These acquired methylation
patterns were accompanied by a metabolic phenotype including
obesity and increased leptin, insulin and glucose levels (Plage-
mann et al., 2009). This study clearly demonstrates epigenetic
programming of POMC by early life nutrition and its effect on
the risk of developing metabolic disorders. Additional inves-
tigations have shown hypermethylation of the POMC proxi-
mal promoter region in 28 day old postnatal mice reared by
dams with dietary supplementation of conjugated linoleic acids
(Zhang et al., 2014). This led to suppression of POMC expression
and increased food intake contributing to catch-up growth and
metabolic changes such as hyperglycaemia and insulin resistance
(Zhang et al., 2014). These results show that changes in early life
nutrition can elicit epigenetic and associated expression changes
in hypothalamic POMC in the offspring.
In a clinical study, Kuehnen et al. (2012) have shown that
hypermethylation of a few distinct CpG sites at the intron 2-exon
3 border (CpG island 2) of the POMC gene from peripheral
blood cell (PBC) DNA was found in obese compared to nor-
mal weight children. This increased methylation was associated
with reduced binding of the p300 histone acetyltransferase and
decreased POMC gene expression in human PBCs. However, it
is difficult to understand how epigenetic changes in the POMC
gene in PBCs relates to changes in the gene in the hypothalamus
as many epigenetic modifications are tissue specific and related to
the function of the gene in one specific tissue. Although, it could
be that the CpG island 2 of the human POMC gene is ametastable
epiallele (Waterland, 2014).
All of these studies indicate that POMC is an emerging can-
didate for epigenetic modifications as a consequence of mater-
nal programming. Despite this, more focused investigations need
to be carried out delineating the full extent of any epigenetic
modifications and the potential mechanisms that may be causing
them. Some of these underlying mechanisms could be associated
with altered dietary factors which act as cofactors of many epi-
genetic modifier enzymes such as DNMTs, HATs, and histone
methyltransferases which are discussed in detail in the later sec-
tion of the review. However, this hypothesis still requires further
investigation.
Programming Epigenetic Changes in the
Hypothalamic GR
GR is a nuclear receptor that is important inmany developmental
and metabolic pathways. It is also involved in the hypothalamic
control of energy homeostasis by regulating the expression of
neuropeptides such as POMC,NPY, andAgRP as discussed above
(Beaulieu et al., 1988; Misaki et al., 1992; Drouin et al., 1993;
Wardlaw et al., 1998; Gyengesi et al., 2010; Lee et al., 2013). Thus,
hypothalamic GR represents a prime candidate for fetal program-
ming which induces alterations in energy balance, predisposing
the offspring to metabolic disorders.
Evidence shows a striking link between effects of maternal
care on the stress response and the epigenetic status of the GR
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gene in the offspring (reviewed in Zhang et al., 2013) indicat-
ing that the GR is a candidate for programming. In a well-
established sheep model of undernutrition, it was shown that
maternal undernourishment resulted in decreased GR promoter
methylation, and alterations in histone modifications associated
with increased GR mRNA expression in the fetal hypothalamic
regions involved in energy balance (Stevens et al., 2010; Begum
et al., 2012). Fascinatingly, these epigenetic alterations of GR per-
sisted up to 5 years of age in adult offspring and were accompa-
nied by decreased POMC mRNA expression. These results show
the enduring nature of the impact on expression changes in the
neuronal networks regulating food intake and energy expendi-
ture (Begum et al., 2013). Interestingly, epigenetic changes in
the GR gene as a result of altered maternal nutrition have been
observed in other tissues such as liver and hippocampus. These
results indicate programming effects on the methylation pat-
terns of tissue-specific alternate first exons or promoters of the
GR gene in the offspring (Lillycrop et al., 2005, 2007; Ke et al.,
2011). Lillycrop et al. (2005) demonstrated that folic acid sup-
plementation to a protein-restricted maternal diet prevented the
epigenetic changes observed in the GR gene in the liver of the off-
spring. These results suggest the role of one-carbon metabolism
in the epigenetic phenotype of the offspring (Lillycrop et al.,
2005). Therefore, dietary alterations of these nutrients could pro-
vide a link between maternal diet and changes in the offspring’s
epigenetic signature.
Epigenetic Alterations in Other Hypothalamic Genes
as a Result of Programming
Altered nutritional experiences during fetal or postnatal life
impact on the epigenetic status of the other key hypothala-
mic genes involved in energy balance. For example, Mahmood
et al. (2013) have shown that feeding new born rats with high-
carbohydrate formula milk resulted in increased mRNA expres-
sion of NPY. This correlated with epigenetic alterations such
as hypomethylation of specific CpG sites and increased H3K9
acetylation in the proximal promoter region of NPY and was
associated with adult-onset obesity (Mahmood et al., 2013).
Interestingly, overfeeding during neonatal life leads to hyper-
methylation in the promoter of the hypothalamic insulin recep-
tor involved in the regulation of food intake and metabolism
(Plagemann et al., 2010). Another study has shown that feed-
ing mice with high fat diet during pregnancy and lactation
resulted in global and promoter hypomethylation of hypothala-
mic dopamine and opioid-related genes in the offspring, lead-
ing to increased expression of these genes. These offspring
showed more preference for palatable food rich in sucrose and
fat (Vucetic et al., 2010). This suggests that dietary modulation
during critical stages of the growth period can also affect epige-
netic regulation of genes involved in food intake, body weight,
and energy homeostasis thereby subsequent risk of developing
obesity and related disorders.
Mechanisms of Changes Induced in the
Epigenome as a Result of Programming
The precise mechanisms causing epigenetic changes induced
by developmental programming is largely unknown. Altered
levels of different nutrients, hormones or stress are likely to be
the mediators of downstream signals of environmental insults.
Micronutrients such as folate, choline, methionine, and vitamins
are methyl group donors that contribute to the production of
SAM through one-carbon metabolism. Since SAM is the univer-
sal methyl donor for both DNA and protein methyltransferases,
variation in its levels can affect methylation patterns. For exam-
ple, methyl donor supplementation to a high fat maternal diet
prevented adverse effects such as body weight gain, behavioural
changes and changes in DNA methylation and gene expres-
sion in the brain that were observed in the offspring of dams
fed high fat diet (Carlin et al., 2013). Another way by which
dietary factors can modify the epigenome is by modulating the
expression or activity of epigenetic modifiers such as DNMTs.
Accordingly, folic acid and other methyl group donors have also
been shown to alter the expression levels of DNMT1, DNMT3a,
and methyl CpG binding proteins involved in epigenetic gene
silencing (Ghoshal et al., 2006; Lillycrop et al., 2007). The activ-
ities of other epigenetic enzymes such as HATs, HDACs, and
demethylases are also susceptible to changes in the levels of cofac-
tors such as acetyl-CoA, NAD, FAD, α-ketoglutarate and thus
respond to altered nutrient intake (reviewed in Kaelin and McK-
night, 2013). Additionally, evidence shows that both glucose and
glucose metabolism induce genome-wide epigenetic alterations
(Pirola et al., 2011). Therefore, it is conceivable that dietary fac-
tors can influence DNA methylation and histone modifications
and thus affect signaling mechanisms regulating energy balance.
However, despite this evidence, it is still not clear how fetal
programming targets gene and tissue specific epigenetic mod-
ifications associated with metabolic disorders. It could be that
the intensity and timing of the insult during early embryogen-
esis may impact the epigenetic alterations in the key metabolic
genes in developing tissues. However, future studies are needed to
understand the mechanisms by which the offspring’s epigenomic
configuration could be altered by maternal diet.
Transgenerational Effects on Epigenetic
Programming of Obesity
Evidence from human and animal studies indicate that devel-
opmental programming of obesity and other metabolic disor-
ders is a transgenerational phenomenon and the transmission of
effects to subsequent generations may occur even in the absence
of exposure to adverse conditions (Aiken and Ozanne, 2014).
Although mechanisms underlying transgenerational transmis-
sion of programming are not clear, evidence shows that it could
be due to epigenetic inheritance via both maternal and paternal
lineages (Vickers, 2014). The involvement of epigenetic mecha-
nisms in transgenerational amplification of obesity was further
confirmed when methyl donor supplementation (e.g., folic acid)
during development prevented the increase in body weight in
subsequent generations caused by maternal obesity (Waterland
et al., 2008). Several studies using animal models have shown
transgenerational effects of maternal under- or over-nutrition
on glucose metabolism (Martin et al., 2000; Benyshek et al.,
2004; Gniuli et al., 2008; Pinheiro et al., 2008; Jimenez-Chillaron
et al., 2009) and cardiovascular and HPA axis function in F2
offspring (Bertram et al., 2008). However, the effect on appetite
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FIGURE 2 | Epigenetic programming of obesity. Altered
nutritional milieu at critical developmental period can program
alterations in the epigenetic signature of hypothalamic appetite
regulatory genes leading to changes in their gene expression
pattern and increased susceptibility to metabolic disorders such
as obesity and diabetes.
regulation in subsequent generations has not been widely studied
and therefore requires further investigation. A complete review
of transgenerational effects on epigenetic programming of obe-
sity is outside the scope of this review. However, understanding
the mechanisms of transgenerational inheritance is important for
the development of intervention strategies tomodulate the effects
of developmental programming of offspring, grandoffspring and
beyond.
Conclusion
The compelling evidence reviewed here clearly shows that early
life nutritional imbalance can induce persistent alterations, deter-
mining the permanent risk of obesity and other metabolic disor-
ders in later life. Furthermore, epigenetic mechanisms might play
an important role in these processes. Maternal under- and over-
nutrition cause altered epigenetic regulation of genes that control
food intake and energy expenditure in the hypothalamic neural
network resulting in lifelong metabolic changes (Figure 2). This
clearly suggests that the rise in the obesity epidemic could be at
least in part explained by early life nutritional imbalances. The
timing and the intensity of such events also seem to have a sig-
nificant role to play in this process. This has led to the hypothesis
that “we are what we eat and also what our mothers ate.” Our
understanding of how environmental stimuli such as nutrition
can induce epigenetic alterations is far from complete and fur-
ther work is required in this area. However, given that there is
clear evidence that these epigenetic modifications are reversible,
there are possibilities that intervention strategies could combat
the rise in obesity.
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